133 Long-term safety and efficacy of elexacaftor-tezacaftor-ivacaftor in children aged 6 and older with cystic fibrosis and at least one F508del allele: 144-week results of an open-label extension study
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: C. Wainwright, S. McColley, P. McNally, M. Powers, F. Ratjen, J. Rayment, G. Retsch-Bogart, E. Roesch, N. Ahluwalia, C. Chu, P. Menon, T. Weinstock, J. Davies, for the VX19-445-107 Study Group Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research